GoldenGolden
Advanced Search
Genesis Therapeutics

Genesis Therapeutics

Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.

All edits

Edits on 6 Aug, 2021
Golden AI"Inferring industry - ai.industry_clf.02"
Golden AI edited on 6 Aug, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Biotechnology
Edits on 15 Jun, 2021
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 15 Jun, 2021
Edits made to:
Article (+13/-13 characters)
Article

Genesis Therapeutics is a company that is interested in providing artificial intelligence and bio-technologies in order to discover new medicines. The company was founded in 2019, in San FranciscoSan Francisco, California, United States.

Edits on 14 Jun, 2021
Erin Scherfner"prospector:324:159510"
Erin Scherfner edited on 14 Jun, 2021
Edits made to:
Infobox (+3 properties)
Edits on 11 May, 2021
Golden AI"Funding autocalculation"
Golden AI edited on 11 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+7 properties)
Infobox
Investors
Edits on 9 Dec, 2020
Golden AI
Golden AI edited on 9 Dec, 2020
Edits made to:
Infobox (+1 properties)
Edits on 6 Dec, 2020
Golden AI
Golden AI edited on 6 Dec, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 6 Dec, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Golden AI
Golden AI edited on 6 Dec, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Dec, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 2 Dec, 2020
Edits made to:
Infobox (+2/-2 properties)
Infobox
Latest funding round date
April 1, 2020
Total funding amount (USD)
4,100,000
Latest funding round date
December 2020
Total funding amount (USD)
56,100,000
Golden AI
Golden AI edited on 2 Dec, 2020
Edits made to:
Infobox (+1 properties)
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
April 1, 2020
Edits on 2 Sep, 2020
Daniel Frumkin"added infobox items, article"
Daniel Frumkin edited on 2 Sep, 2020
Edits made to:
Infobox (+4/--3 properties)
Article (+574 characters)
Article

Genesis Therapeutics is a company that is interested in providing artificial intelligence and bio-technologies in order to discover new medicines. The company was founded in 2019, in San Francisco, California, United States.

The company looks to combine novel deep neural networks, biophysical simulations, and computing infrastructures. The company has an artificial intelligence platform that expands the initial discovery of the PotentialNet and peer-reviewed methods for molecular property predictions. Their methods have been tested against current methods of chemistry.

Infobox
Business model
Commerce
Company status
Active
Email address
info@genesistherapeutics.ai
Edits on 31 Aug, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 31 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
4,100,000
Golden AI
Golden AI edited on 31 Aug, 2020
Edits made to:
Infobox (+1 properties)
Golden AI
Golden AI edited on 31 Aug, 2020
Edits made to:
Infobox (+1 properties)
Holden Page
Holden Page edited on 31 Aug, 2020
Edits made to:
Description (+160 characters)
Topic thumbnail

Genesis Therapeutics

Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.

Edits on 4 Jun, 2020
Golden AI
Golden AI edited on 4 Jun, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Jun, 2020
Dawson Sewell
Dawson Sewell edited on 3 Jun, 2020
Edits made to:
Infobox (+3 properties)
Infobox
Industry
Dawson Sewell"Initial creation data"
Dawson Sewell edited on 3 Jun, 2020
Edits made to:
Infobox (+2 properties)
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.